Literature DB >> 26223878

The unpredictable consequences of CDKN1B/p27Kip1 mutations in cancer.

Adriana Borriello1, Debora Bencivenga1, Fulvio Della Ragione1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26223878      PMCID: PMC4825553          DOI: 10.1080/15384101.2015.1076302

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

Review 1.  Haplo-insufficiency: a driving force in cancer.

Authors:  Alice H Berger; Pier Paolo Pandolfi
Journal:  J Pathol       Date:  2010-10-29       Impact factor: 7.996

Review 2.  p27kip1: a new multiple endocrine neoplasia gene?

Authors:  Ilaria Marinoni; Natalia S Pellegata
Journal:  Neuroendocrinology       Date:  2010-10-27       Impact factor: 4.914

3.  Recurrent CDKN1B (p27) mutations in hairy cell leukemia.

Authors:  Sascha Dietrich; Jennifer Hüllein; Stanley Chun-Wei Lee; Barbara Hutter; David Gonzalez; Sandrine Jayne; Martin J S Dyer; Małgorzata Oleś; Monica Else; Xiyang Liu; Mikołaj Słabicki; Bian Wu; Xavier Troussard; Jan Dürig; Mindaugas Andrulis; Claire Dearden; Christof von Kalle; Martin Granzow; Anna Jauch; Stefan Fröhling; Wolfgang Huber; Manja Meggendorfer; Torsten Haferlach; Anthony D Ho; Daniela Richter; Benedikt Brors; Hanno Glimm; Estella Matutes; Omar Abdel Wahab; Thorsten Zenz
Journal:  Blood       Date:  2015-06-11       Impact factor: 22.113

4.  P27Kip1 serine 10 phosphorylation determines its metabolism and interaction with cyclin-dependent kinases.

Authors:  Debora Bencivenga; Annunziata Tramontano; Alessia Borgia; Aide Negri; Ilaria Caldarelli; Adriana Oliva; Silverio Perrotta; Fulvio Della Ragione; Adriana Borriello
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

5.  The murine gene p27Kip1 is haplo-insufficient for tumour suppression.

Authors:  M L Fero; E Randel; K E Gurley; J M Roberts; C J Kemp
Journal:  Nature       Date:  1998-11-12       Impact factor: 49.962

6.  The landscape of cancer genes and mutational processes in breast cancer.

Authors:  Philip J Stephens; Patrick S Tarpey; Helen Davies; Peter Van Loo; Chris Greenman; David C Wedge; Serena Nik-Zainal; Sancha Martin; Ignacio Varela; Graham R Bignell; Lucy R Yates; Elli Papaemmanuil; David Beare; Adam Butler; Angela Cheverton; John Gamble; Jonathan Hinton; Mingming Jia; Alagu Jayakumar; David Jones; Calli Latimer; King Wai Lau; Stuart McLaren; David J McBride; Andrew Menzies; Laura Mudie; Keiran Raine; Roland Rad; Michael Spencer Chapman; Jon Teague; Douglas Easton; Anita Langerød; Ming Ta Michael Lee; Chen-Yang Shen; Benita Tan Kiat Tee; Bernice Wong Huimin; Annegien Broeks; Ana Cristina Vargas; Gulisa Turashvili; John Martens; Aquila Fatima; Penelope Miron; Suet-Feung Chin; Gilles Thomas; Sandrine Boyault; Odette Mariani; Sunil R Lakhani; Marc van de Vijver; Laura van 't Veer; John Foekens; Christine Desmedt; Christos Sotiriou; Andrew Tutt; Carlos Caldas; Jorge S Reis-Filho; Samuel A J R Aparicio; Anne Vincent Salomon; Anne-Lise Børresen-Dale; Andrea L Richardson; Peter J Campbell; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2012-05-16       Impact factor: 49.962

7.  Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.

Authors:  Joshua M Francis; Adam Kiezun; Alex H Ramos; Stefano Serra; Chandra Sekhar Pedamallu; Zhi Rong Qian; Michaela S Banck; Rahul Kanwar; Amit A Kulkarni; Anna Karpathakis; Veronica Manzo; Tanupriya Contractor; Juliet Philips; Elizabeth Nickerson; Nam Pho; Susanne M Hooshmand; Lauren K Brais; Michael S Lawrence; Trevor Pugh; Aaron McKenna; Andrey Sivachenko; Kristian Cibulskis; Scott L Carter; Akinyemi I Ojesina; Samuel Freeman; Robert T Jones; Douglas Voet; Gordon Saksena; Daniel Auclair; Robert Onofrio; Erica Shefler; Carrie Sougnez; Jonna Grimsby; Lisa Green; Niall Lennon; Tim Meyer; Martyn Caplin; Daniel C Chung; Andreas S Beutler; Shuji Ogino; Christina Thirlwell; Ramesh Shivdasani; Sylvia L Asa; Chris R Harris; Gad Getz; Matthew Kulke; Matthew Meyerson
Journal:  Nat Genet       Date:  2013-11-03       Impact factor: 38.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.